Nicotinamide and Aimovig drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nicotinamide (niacin and niacinamide (vitamin b3)) and Aimovig (erenumab-aooe). Common drug interactions include pain among females.

The phase IV clinical study analyzes what interactions people have when they take Nicotinamide and Aimovig. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Nicotinamide?

Nicotinamide has active ingredients of niacin and niacinamide (vitamin b3). eHealthMe is studying from 1,991 Nicotinamide users. Check the latest studies of Nicotinamide.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.

On Jul, 25, 2026

64 people who take Nicotinamide and Aimovig together, and have interactions are studied.

Nicotinamide and Aimovig drug interactions.

What are the common drug interactions of Nicotinamide and Aimovig, by gender? *:

female:

Pain
Drug ineffective
Vomiting
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters)
Pericarditis (inflammation of the pericardium)
Blepharospasm (any abnormal contraction or twitch of the eyelid)
C-reactive protein increased
Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)

male:

n/a

What are the common drug interactions of Nicotinamide and Aimovig, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Drug intolerance (drug sensitivity)
Memory impairment
Injection site reaction
Vomiting
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters)
Pericarditis (inflammation of the pericardium)
Blepharospasm (any abnormal contraction or twitch of the eyelid)
C-reactive protein increased
Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)

50-59:

n/a

60+:

Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Retinal deposits
Retinal pigment epitheliopathy (disease of pigment epithelium)

What are the existing conditions these people have? *

Migraine (headache): 61 people, 95.31%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 50 people, 78.12%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 49 people, 76.56%
Psoriasis (immune-mediated disease that affects the skin): 41 people, 64.06%

* Approximation only. Some reports may have incomplete information.

Do you take Nicotinamide and Aimovig?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously